PeterPoon-HangLeeMD
Hematology • Duarte, CAHematologic Oncology
Billy Wilder Endowed Professor and Chair, Dept. of Immuno-Oncology, City of Hope Comprehensive Cancer Center
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-359-8111
Summary
- Dr. Peter P. Lee is a hematologist in Duarte, CA and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from University of California San Diego School of Medicine and has been in practice 28 years. He specializes in hematologic oncology and is experienced in hematologic oncology. Dr. Lee primarily conducts translational research in cancer immunology and immunotherapy. He is Chair of the Department of Immuno-Oncology at the Beckman Research Institute.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1995 - 1999
University of California (San Francisco) School of MedicineFellowship, Allergy and Immunology, 1992 - 1994
Scripps Clinic/Scripps Green HospitalResidency, Internal Medicine, 1989 - 1992
University of California San Diego School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1990 - 2026
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2006
Publications & Presentations
PubMed
- Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood.Brian Orcutt-Jahns, Joao Rodrigues Lima Junior, Emily Lin, Russell C Rockne, Adina Matache
NPJ Systems Biology and Applications. 2024-10-10 - Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment.Weihua Guo, Jiayi Tan, Lei Wang, Colt A Egelston, Diana L Simons
Nature Communications. 2024-10-04 - 4 citationsCabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.Hedyeh Ebrahimi, Nazli Dizman, Luis Meza, Jasnoor Malhotra, Xiaochen Li
Nature Medicine. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
